Healthcare provider profile · identity verified

Jonah Burke, DO

Family Practice · FAYETTEVILLE, PA · NPI 1376954586

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	513	157
Lisinopril	Lisinopril	463	129
Levothyroxine Sodium	Levothyroxine Sodium	338	93
Amlodipine Besylate	Amlodipine Besylate	293	80
Metoprolol Succinate	Metoprolol Succinate	276	74
Metformin Hcl	Metformin Hcl	274	77
Omeprazole	Omeprazole	261	73
Hydrochlorothiazide	Hydrochlorothiazide	226	64
Gabapentin	Gabapentin	213	55
Losartan Potassium	Losartan Potassium	192	56
Simvastatin	Simvastatin	192	60
Rosuvastatin Calcium	Rosuvastatin Calcium	170	48
Furosemide	Furosemide	163	52
Pantoprazole Sodium	Pantoprazole Sodium	147	49
Januvia	Sitagliptin Phosphate	143	31
Famotidine	Famotidine	141	38
Pravastatin Sodium	Pravastatin Sodium	124	32
Metoprolol Tartrate	Metoprolol Tartrate	117	38
Duloxetine Hcl	Duloxetine Hcl	107	30
Tramadol Hcl	Tramadol Hcl	107	24
Sertraline Hcl	Sertraline Hcl	102	39
Valsartan	Valsartan	99	29
Synthroid	Levothyroxine Sodium	98	28
Tamsulosin Hcl	Tamsulosin Hcl	98	26
Fluticasone Propionate	Fluticasone Propionate	93	43
Montelukast Sodium	Montelukast Sodium	86	20
Albuterol Sulfate Hfa	Albuterol Sulfate	85	35
Escitalopram Oxalate	Escitalopram Oxalate	82	20
Trazodone Hcl	Trazodone Hcl	78	23
Potassium Chloride	Potassium Chloride	76	27
Allopurinol	Allopurinol	74	21
Jardiance	Empagliflozin	74	17
Zolpidem Tartrate	Zolpidem Tartrate	73	17
Buspirone Hcl	Buspirone Hcl	71	16
Eliquis	Apixaban	67	23
Clopidogrel	Clopidogrel Bisulfate	65	21
Glipizide Er	Glipizide	58	16
Warfarin Sodium	Warfarin Sodium	57	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	17
Metformin Hcl Er	Metformin Hcl	55	20
Carvedilol	Carvedilol	50	16
Fluoxetine Hcl	Fluoxetine Hcl	50	13
Oxycodone Hcl	Oxycodone Hcl	50	suppressed
Alendronate Sodium	Alendronate Sodium	49	16
Ezetimibe	Ezetimibe	49	17
Ozempic	Semaglutide	46	suppressed
Alprazolam	Alprazolam	44	16
Bupropion Xl	Bupropion Hcl	44	suppressed
Glipizide	Glipizide	44	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	14
Morphine Sulfate Er	Morphine Sulfate	43	suppressed
Lovastatin	Lovastatin	42	11
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Lorazepam	Lorazepam	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	34	suppressed
Finasteride	Finasteride	33	suppressed
Meloxicam	Meloxicam	33	12
Azelastine Hcl	Azelastine Hcl	32	12
Donepezil Hcl	Donepezil Hcl	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Enalapril Maleate	Enalapril Maleate	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	12
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	15
Celecoxib	Celecoxib	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Ramipril	Ramipril	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Atenolol	Atenolol	24	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	23	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	21	16
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Prednisone	Prednisone	20	19
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Ondansetron Odt	Ondansetron	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Diazepam	Diazepam	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Azithromycin	Azithromycin	16	16
Chlorthalidone	Chlorthalidone	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Methimazole	Methimazole	16	suppressed
Temazepam	Temazepam	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Humalog	Insulin Lispro	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	13	13
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Cephalexin	Cephalexin	13	12
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	12
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Novolin N	Insulin Nph Human Isophane	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Repatha Syringe	Evolocumab	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Baclofen	Baclofen	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Irbesartan	Irbesartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error